Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
Clinical Trials Tuesday, August 7th, 2012Nber.org: 7/19/12
We examine the impact of pharmaceutical innovation, as measured by the vintage of prescription drugs used, on longevity, using longitudinal, country-level data on 30 developing and high-income countries during the period 2000-2009. We control for fixed country and year effects, real per capita income, the unemployment rate, mean years of schooling, the urbanization rate, real per capita health expenditure (public and private), the DPT immunization rate, HIV prevalence and tuberculosis incidence. Read More